United States · FDA National Drug Code directory
LABETALOL HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-468_4e7597b8-afba-8b90-e063-6394a90a85e4
- Product NDC
- 72888-468
- Form
- TABLET, FILM COATED
- Composition / generic term
- Labetalol Hydrochloride
- Labeler
- Advagen Pharma Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250520
- Source listing expiry
- 20271231
Source-listed ingredients
- LABETALOL HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (72888-468-01) · 72888-468-01
- 100 TABLET, FILM COATED in 1 BOTTLE (72888-468-02) · 72888-468-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →